213 related articles for article (PubMed ID: 21318564)
41. D-cycloserine reduces the context specificity of pavlovian extinction of cocaine cues through actions in the nucleus accumbens.
Torregrossa MM; Sanchez H; Taylor JR
J Neurosci; 2010 Aug; 30(31):10526-33. PubMed ID: 20685995
[TBL] [Abstract][Full Text] [Related]
42. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving.
Ray LA; Chin PF; Heydari A; Miotto K
Psychopharmacology (Berl); 2011 Oct; 217(3):341-51. PubMed ID: 21487653
[TBL] [Abstract][Full Text] [Related]
43. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
44. Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.
Bolkan SS; Lattal KM
Neurobiol Learn Mem; 2014 Sep; 113():25-34. PubMed ID: 24374132
[TBL] [Abstract][Full Text] [Related]
45. Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice.
Groblewski PA; Lattal KM; Cunningham CL
Alcohol Clin Exp Res; 2009 May; 33(5):772-82. PubMed ID: 19298331
[TBL] [Abstract][Full Text] [Related]
46. A high-throughput clinical assay for testing drug facilitation of exposure therapy.
Rodebaugh TL; Levinson CA; Lenze EJ
Depress Anxiety; 2013 Jul; 30(7):631-7. PubMed ID: 23283838
[TBL] [Abstract][Full Text] [Related]
47. Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting.
Johnson MW; Bruner NR; Johnson PS; Silverman K; Berry MS
Exp Clin Psychopharmacol; 2020 Apr; 28(2):157-168. PubMed ID: 31368770
[TBL] [Abstract][Full Text] [Related]
48. D-cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats.
Vengeliene V; Kiefer F; Spanagel R
Alcohol Alcohol; 2008; 43(6):626-9. PubMed ID: 18945754
[TBL] [Abstract][Full Text] [Related]
49. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.
Fox HC; Anderson GM; Tuit K; Hansen J; Kimmerling A; Siedlarz KM; Morgan PT; Sinha R
Alcohol Clin Exp Res; 2012 Feb; 36(2):351-60. PubMed ID: 21919922
[TBL] [Abstract][Full Text] [Related]
50. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
51. Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence.
Krystal JH; Petrakis IL; Limoncelli D; Nappi SK; Trevisan L; Pittman B; D'Souza DC; Suckow RF
Neuropsychopharmacology; 2011 Feb; 36(3):701-10. PubMed ID: 21124304
[TBL] [Abstract][Full Text] [Related]
52. d-Cycloserine facilitates extinction learning and enhances extinction-related brain activation.
Klass A; Glaubitz B; Tegenthoff M; Lissek S
Neurobiol Learn Mem; 2017 Oct; 144():235-247. PubMed ID: 28807795
[TBL] [Abstract][Full Text] [Related]
53. D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues.
Baker KD; McNally GP; Richardson R
Learn Mem; 2012 Sep; 19(10):461-9. PubMed ID: 22984284
[TBL] [Abstract][Full Text] [Related]
54. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on sexual memory consolidation in women.
Both S; Van Veen RJB; Brom M; Weijenborg PTM
Psychopharmacology (Berl); 2020 May; 237(5):1291-1303. PubMed ID: 31984445
[TBL] [Abstract][Full Text] [Related]
55. Amygdaloid zif268 participated in the D-cycloserine facilitation effect on the extinction of conditioned fear.
Wu IT; Tang TH; Ko MC; Chiu CY; Lu KT
Psychopharmacology (Berl); 2015 Oct; 232(20):3809-19. PubMed ID: 26282370
[TBL] [Abstract][Full Text] [Related]
56. Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes.
Rohsenow DJ; Monti PM; Rubonis AV; Gulliver SB; Colby SM; Binkoff JA; Abrams DB
Addiction; 2001 Aug; 96(8):1161-74. PubMed ID: 11487422
[TBL] [Abstract][Full Text] [Related]
57. [Pharmacological support of exposure therapy in anxiety disorders. Animal experiment studies].
Koch M
Nervenarzt; 2002 May; 73(5):481-3. PubMed ID: 12078031
[TBL] [Abstract][Full Text] [Related]
58. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.
Hofmann SG; Papini S; Carpenter JK; Otto MW; Rosenfield D; Dutcher CD; Dowd S; Lewis M; Witcraft S; Pollack MH; Smits JAJ
PLoS One; 2019; 14(10):e0223729. PubMed ID: 31622374
[TBL] [Abstract][Full Text] [Related]
59. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder.
Storch EA; Murphy TK; Goodman WK; Geffken GR; Lewin AB; Henin A; Micco JA; Sprich S; Wilhelm S; Bengtson M; Geller DA
Biol Psychiatry; 2010 Dec; 68(11):1073-6. PubMed ID: 20817153
[TBL] [Abstract][Full Text] [Related]
60. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
